Merck pays Moderna $250m for personalized cancer vaccine

Merck pays Moderna $250m for personalized cancer vaccine

Comments

Popular posts from this blog

A 10-Second Steam Blast: The New Weapon Against Prostate Cancer?

Dr. Christopher Kane of UCSD Health Appointed Chairman of the American Board of Urology

Researchers develop low-cost device that detects cancer in an hour | ScienceDaily